Oxford Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Buy
+8,339
New +$232K 0.12% 269
2025
Q4
Sell
-87,151
Closed -$2.34M 735
2025
Q3
$2.34M Buy
+87,151
New +$2.08M 0.77% 19
2020
Q1
Sell
-11,573
Closed -$407K 1165
2019
Q4
$407K Buy
+11,573
New +$382K 0.01% 1326
2019
Q2
Sell
-5,965
Closed -$204K 1947
2019
Q1
$204K Sell
5,965
-785
-12% -$27.8K ﹤0.01% 1509
2018
Q4
$215K Sell
6,750
-93,101
-93% -$3.63M 0.01% 1515
2018
Q3
$4.78M Sell
99,851
-32,259
-24% -$1.32M 0.1% 235
2018
Q2
$4.1M Buy
132,110
+95,505
+261% +$2.23M 0.08% 278
2018
Q1
$542K Buy
36,605
+11,861
+48% +$185K 0.01% 1211
2017
Q4
$393K Buy
+24,744
New +$368K 0.01% 1259
2016
Q2
Sell
-23,262
Closed -$172K 871
2016
Q1
$172K Sell
23,262
-17,080
-42% -$116K ﹤0.01% 722
2015
Q4
$290K Buy
+40,342
New +$327K 0.01% 751

Other funds holding STAA

Oxford Asset Management's STAA Position: Q2 2026 in Review

Oxford Asset Management opened a new position in STAAR Surgical (STAA) in Q2 2026: 8,339 shares worth $239K. The stake represents 0.12% of the portfolio and ranks #269 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in STAA as recently as Q3 2025.

Oxford Asset Management first reported a position in STAA in Q4 2015 and has held it in 11 quarters since. The position peaked at $4.78M in Q3 2018. 201 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Oxford Asset Management held 8,339 shares of STAAR Surgical worth $239K as of Q2 2026.
  • STAAR Surgical was a new Oxford Asset Management position in Q2 2026.
  • STAAR Surgical made up 0.12% of Oxford Asset Management's portfolio in Q2 2026, its #269 holding.
  • Oxford Asset Management first reported a position in STAAR Surgical in Q4 2015 and has held it in 11 quarters since.
  • Oxford Asset Management's STAAR Surgical position peaked at $4.78M in Q3 2018.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.